These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 883324

  • 1. Urinary hydroxyproline in the management of breast cancer.
    Cuschieri A.
    World J Surg; 1977 May; 1(3):299-302. PubMed ID: 883324
    [No Abstract] [Full Text] [Related]

  • 2. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J, Jordal R, Riskoer N.
    Ugeskr Laeger; 1968 Oct 17; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract] [Full Text] [Related]

  • 3. Urinary hydroxyproline excretion in patients with breast cancer.
    Cuschieri A, Felgate R.
    Br J Surg; 1971 Nov 17; 58(11):862. PubMed ID: 5124876
    [No Abstract] [Full Text] [Related]

  • 4. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ, Leese CL, Bondy PK.
    Br Med J; 1975 Apr 26; 2(5964):164-6. PubMed ID: 1125725
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB, Depierre D, Alberto P, Courvoisier B.
    Schweiz Med Wochenschr; 1977 Jul 16; 107(28):984-6. PubMed ID: 897640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J, Jordal R, Riskaer N.
    Acta Endocrinol (Copenh); 1968 Nov 16; 59(3):353-61. PubMed ID: 5754976
    [No Abstract] [Full Text] [Related]

  • 11. The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
    Mirejovská E, Beska F, Pitronová M.
    Neoplasma; 1968 Nov 16; 15(4):433-8. PubMed ID: 5684467
    [No Abstract] [Full Text] [Related]

  • 12. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
    Rico Lenza H, Millán Núñez-Cortés J, Rodríguez Mora VI, Espinós Pérez D.
    Rev Esp Oncol; 1980 Nov 16; 27(1):61-6. PubMed ID: 7209108
    [Abstract] [Full Text] [Related]

  • 13. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
    Radom S, Zulawski M, Dahlig E.
    Clin Chim Acta; 1972 Jun 16; 39(1):277-8. PubMed ID: 4556834
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A, Pedelini G, Colalongo G, Biagi R, Mambelli M, Jafelice G, Rocchetta G, Piana E, Pannuti F.
    Minerva Med; 1980 Sep 01; 71(31):2215-9. PubMed ID: 7422143
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
    Cuschieri A.
    Br J Surg; 1973 Oct 01; 60(10):800-3. PubMed ID: 4748385
    [No Abstract] [Full Text] [Related]

  • 20. Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
    Cuschieri A, Jarvie R, Taylor WH, Cant E, Furnival CM, Blumgart LH.
    Br J Cancer; 1978 Jun 01; 37(6):1002-5. PubMed ID: 678421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.